Revised MRPs for 1,364 anti-cancer drugs come into effect

The Ministry of Health has implemented revised maximum retail prices for 1,364 anti-cancer formulations across 121 drugs. Eighty-five pharmaceutical companies have complied with these changes as of November 8, 2026. This initiative is expected to provide significant financial relief to patients, resulting in annual savings of approximately ₹3,540 crore for consumers nationwide.